Evidence map›Paper›PMID 39483862›Full record

ReviewGalen medical journal2024

Impact of Wearable Technology on Heart Failure Management.

Negar Jafari, Sahar Yousefi Ghalati, Venus Shahabi Raberi, Saba Moalemi, Arash Amin

Abstract readReview
In one paragraph

Review in Galen medical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Negar JafariDepartment of Cardiology, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
Sahar Yousefi GhalatiSchool of Nursing and Midwifery, Shiraz University of Medical Sciences, Shiraz, Iran.
Venus Shahabi RaberiInternational Training Fellow of cardiology, Wwl Nhs Trust, UK.
Saba MoalemiDepartment of Managment, Shiraz Branch, Islamic Azad University, Shiraz, Iran.
Arash AminLorestan Heart Center (Madani Hospital), Lorestan University of Medical Sciences, Khorram-Abad, Lorestan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHeart failure (HF) is a chronic and progressive condition that its management presents significant challenges in both clinical settings and patient self-care. Recent advances in wearable technology offer promising solutions to these challenges by enabling continuous monitoring, early detection of clinical deterioration, and personalized care. This review aims to critically evaluate the impact of wearable technology on HF management Materials and Methods: This narrative systematic review was conducted across multiple databases, including PubMed, Web of Science, and the Cochrane Library, to identify relevant studies published between 2010 and 2024. Studies on wearable devices for HF management and monitoring were included if they reported on clinical trials and provided data on integration into clinical workflows. Studies on other conditions or without original research data or Non-English papers were excluded.

resultsNine studies were evaluated in this study that were focusing on a variety of technologies ranging from consumer-grade fitness trackers to specialized bioimpedance sensors and wearable cardioverter-defibrillators. These studies demonstrate the potential of wearables to continuously monitor important health metrics, which can lead to early intervention and personalized care. However, there are still challenges to be addressed, including concerns about data accuracy, patient adherence, small sample sizes, and the incorporation of wearable data into clinical practice. While consumer devices are more accessible, their accuracy in a clinical setting is uncertain, while more advanced devices like the "Volum" monitor and BioZ sensors show promise but require further validation.

conclusionThis review highlights the growing importance of wearable technologies in HF management, actionable insights that can prevent disease progression. However, significant challenges remain, including the need for further validation, device optimization, and data standardization before routine clinical practice. Future advancements should focus on improving device accuracy, patient adherence, and data security, while ensuring equitable access to these technologies.

Indexed as

Artificial IntelligenceBiosensorHeart FailureMonitoringMyocardial InfarctionSmartwatchWearable Technology

Identifiers

PMID39483862
PMCPMC11525106

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.